Your browser doesn't support javascript.
loading
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012).
Chen, Heyan; Maimaitiaili, Amina; Liu, Zhenzhen; Ling, Rui; Zhao, Yi; Yang, Hongjian; Liu, Yunjiang; Liu, Ke; Zhang, Jianguo; Mao, Dahua; Yu, Zhigang; Liu, Yinhua; Fu, Peifen; Wang, Jiandong; Jiang, Hongchuan; Zhao, Zuowei; Tian, Xingsong; Cao, Zhongwei; Wu, Kejin; Song, Ailin; Jin, Feng; He, Jianjun; Fan, Zhimin; Zhang, Huimin.
Afiliación
  • Chen H; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Maimaitiaili A; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Liu Z; Department of Breast Disease, Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China.
  • Ling R; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Zhao Y; Surgical Oncology Department, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Yang H; Department of Breast Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Liu Y; Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Liu K; Fourth Department of Breast Surgery, Jilin Cancer Hospital, Changchun, Jilin, China.
  • Zhang J; Department of Breast Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  • Mao D; Department of Breast Surgery, Affiliated Wudang Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Yu Z; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Liu Y; Breast Disease Center, Peking University First Hospital, Beijing, China.
  • Fu P; Department of Breast Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Wang J; Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Jiang H; Department of Breast Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Zhao Z; Department of Breast Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Tian X; Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China.
  • Cao Z; Department of Thyroid, Breast, Hernia Surgery, The Inner Mongolia Autonomous Region People's Hospital, Hohhot, Inner Mongolia Autonomous Region, China.
  • Wu K; Department of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Song A; Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
  • Jin F; Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • He J; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi 710061, China.
  • Fan Z; Department of Breast Surgery, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, Jilin 130021, China.
  • Zhang H; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi 710061, China.
Ther Adv Med Oncol ; 15: 17588359231156146, 2023.
Article en En | MEDLINE | ID: mdl-36891484

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2023 Tipo del documento: Article País de afiliación: China